Dr. Rona D. Yaeger, MD

Dr. Yaeger practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Yaeger's NPI, 1790931384, was assigned on August 14, 2008. Dr. Yaeger graduated from New York University Grossman School of Medicine in 2003. Dr. Yaeger holds New York license 234493.

Dr. Yaeger's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Yaeger's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Yaeger to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yaeger practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Yaeger's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Yaeger is licensed in New York.

Dmand AI lists chronic anemia and colorectal cancer among the conditions Dr. Yaeger treats.

CMS data shows 329 Medicare services from Dr. Yaeger across 3 procedure codes in 2024, all of them office visits, for 102 Medicare patients. Medicare paid $25,411 for them. Every service was in an office.

CMS counts 102 Medicare patients who saw Dr. Yaeger in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have cancer, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yaeger's median patient age at 71, with 52% women.

In 2024, Dr. Yaeger wrote 201 Medicare Part D claims for 48 patients. 84% of them were for generic drugs. CMS names the drug for 77 of them, across 4 drugs with 11 or more claims each, at $1,234 in total drug cost. In 2023, CMS named 111 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Yaeger for performance year 2024, reported as part of a group. Dr. Yaeger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yaeger as offering telehealth.

Dmand AI links 128 papers to Dr. Yaeger, published from 2014 to 2025. 2024 was the busiest year, with 17. The most frequent topics are Colorectal Neoplasms, Proto-Oncogene Proteins B-raf and Biomarkers, Tumor. Dr. Yaeger has published most often in Clin Cancer Res. Dr. Yaeger's most frequent co-authors are Jinru Shia, MD, Jaclyn Frances Hechtman, MD and Leonard Saltz, MD.

CMS Open Payments shows 27 general payments to Dr. Yaeger from 6 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 81% of the total. Merck Sharp & Dohme Corporation paid the most, $17,318. It also lists 61 research payments totaling $70,474 from 2020 to 2025.

Dr. Yaeger graduated from New York University Grossman School of Medicine in 2003.

Dr. Yaeger is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.